Mason Street Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-54,673
| Closed | -$25.5M | – | 1130 |
|
|
2020
Q4 | $25.5M | Sell |
54,673
-888
| -2% | -$416K | 0.43% | 35 |
|
|
2020
Q3 | $24.5M | Sell |
55,561
-824
| -1% | -$340K | 0.48% | 32 |
|
|
2020
Q2 | $20.4M | Sell |
56,385
-827
| -1% | -$277K | 0.41% | 41 |
|
|
2020
Q1 | $16.2M | Hold |
57,212
| – | – | 0.37% | 48 |
|
|
2019
Q4 | $18.6M | Buy |
57,212
+157
| +0.3% | +$47.6K | 0.36% | 48 |
|
|
2019
Q3 | $16.6M | Buy |
57,055
+11
| +0% | +$3.15K | 0.34% | 52 |
|
|
2019
Q2 | $16.8M | Sell |
57,044
-389
| -0.7% | -$107K | 0.35% | 48 |
|
|
2019
Q1 | $15.7M | Buy |
57,433
+676
| +1% | +$168K | 0.32% | 59 |
|
|
2018
Q4 | $12.7M | Buy |
56,757
+132
| +0.2% | +$31K | 0.31% | 59 |
|
|
2018
Q3 | $13.8M | Buy |
56,625
+178
| +0.3% | +$40.9K | 0.29% | 66 |
|
|
2018
Q2 | $11.7M | Buy |
56,447
+479
| +0.9% | +$102K | 0.26% | 66 |
|
|
2018
Q1 | $11.6M | Buy |
55,968
+113
| +0.2% | +$23.7K | 0.26% | 67 |
|
|
2017
Q4 | $10.6M | Buy |
55,855
+299
| +0.5% | +$57.3K | 0.24% | 77 |
|
|
2017
Q3 | $10.5M | Buy |
55,556
+1,259
| +2% | +$228K | 0.25% | 73 |
|
|
2017
Q2 | $9.47M | Buy |
54,297
+348
| +0.6% | +$58.5K | 0.24% | 75 |
|
|
2017
Q1 | $8.29M | Sell |
53,949
-89
| -0.2% | -$13.6K | 0.21% | 86 |
|
|
2016
Q4 | $7.63M | Buy |
54,038
+702
| +1% | +$103K | 0.21% | 92 |
|
|
2016
Q3 | $8.48M | Buy |
53,336
+332
| +0.6% | +$51.2K | 0.24% | 74 |
|
|
2016
Q2 | $7.83M | Buy |
53,004
+221
| +0.4% | +$32.6K | 0.23% | 84 |
|
|
2016
Q1 | $7.47M | Buy |
52,783
+645
| +1% | +$86.4K | 0.23% | 84 |
|
|
2015
Q4 | $7.4M | Buy |
52,138
+579
| +1% | +$77.2K | 0.23% | 85 |
|
|
2015
Q3 | $6.3M | Buy |
51,559
+304
| +0.6% | +$39.6K | 0.21% | 92 |
|
|
2015
Q2 | $6.65M | Buy |
51,255
+156
| +0.3% | +$20.3K | 0.2% | 96 |
|
|
2015
Q1 | $6.87M | Sell |
51,099
-13,924
| -21% | -$1.8M | 0.21% | 97 |
|
|
2014
Q4 | $8.15M | Sell |
65,023
-278
| -0.4% | -$33.8K | 0.06% | 381 |
|
|
2014
Q3 | $7.95M | Sell |
65,301
-178
| -0.3% | -$21.6K | 0.06% | 365 |
|
|
2014
Q2 | $7.73M | Buy |
65,479
+1,723
| +3% | +$203K | 0.06% | 386 |
|
|
2014
Q1 | $7.67M | Buy |
63,756
+3,790
| +6% | +$451K | 0.06% | 364 |
|
|
2013
Q4 | $6.68M | Sell |
59,966
-8,007
| -12% | -$796K | 0.05% | 388 |
|
|
2013
Q3 | $6.26M | Sell |
67,973
-7,667
| -10% | -$693K | 0.07% | 300 |
|
|
2013
Q2 | $6.4M | Buy |
+75,640
| New | +$6.3M | 0.07% | 314 |
|
Other funds holding TMO
Mason Street Advisors's TMO Position: Q1 2021 in Review
Mason Street Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 54,673 shares — an estimated $25.5M sold.
Mason Street Advisors first reported a position in TMO in Q2 2013 and held it in 31 quarters. The position peaked at $25.5M in Q4 2020. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.
- Mason Street Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 54,673 Thermo Fisher Scientific shares in Q1 2021, an estimated $25.5M.
- Mason Street Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Thermo Fisher Scientific position peaked at $25.5M in Q4 2020.
- 2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.